Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_2
2
25%
Ph phase_3
2
25%
Ph phase_4
1
13%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 32 (25.0%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

completed563%
unknown225%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_3

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567
completedphase_4

Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients

NCT00564564
unknownnot_applicable

Interpersonal Psychotherapy for Treatment Resistant Depression

NCT01896349
completednot_applicable

Predicting Medication Response in Obsessive Compulsive Disorder

NCT01404871
completedphase_2

Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation

NCT01203202
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT00564564Phase 4

Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients

Completed
NCT01896349Not Applicable

Interpersonal Psychotherapy for Treatment Resistant Depression

Unknown
NCT01404871Not Applicable

Predicting Medication Response in Obsessive Compulsive Disorder

Completed
NCT01203202Phase 2

Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation

Completed
NCT01439984Phase 3

Trial of PED-1 in Male Patients With Premature Ejaculation

Completed
NCT01575158Not Applicable

Citalopram vs Clomipramine vs Placebo in Recurrent Depression

Completed
NCT00004310Phase 2

Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8